Cipla Q1 FY25 results: Net profit up 25% at Rs 988 crore, revenue rises 9%
Cipla boasts a robust net cash balance of Rs 8,449 crore. Debt obligations primarily pertain to lease liabilities and working
Continue reading
Tag: US business
Broker’s call: Ajanta Pharma (Add)
Target: ₹2,556 CMP: ₹2,329.35 Over the last five years, Ajanta Pharma’s ROE has improved by about 400-500bps led by buybacks.
Continue reading